Centeon Kankakee, Ill. plant resumes production pursuant to consent decree with FDA.
Executive Summary
CENTEON TO RESUME PRODUCTION AT KANKAKEE, IL. PLANT UNDER CONSENT DECREE between FDA and the blood products company; the consent decree will be filed the week of Jan. 27. The Rhone-Poulenc Rorer and Hoechst joint venture Centeon halted operations at the Kankakee facility in October following a series of plasma product recalls due to suspected bacterial contamination from vial cracks ("The Pink Sheet" Oct. 14, 1996, T&G-7).